Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
XOMA Royalty Corporation Announces Cash Dividends for Series A and Series B Preferred Stock Quiver Quantitative, Inc. - Thu Dec 19, 4:52PM CST

XOMA Royalty Corporation announces upcoming cash dividends for Series A and B Preferred Stock, payable January 15, 2025.Quiver AI SummaryXOMA Royalty Corporation has announced that its Board of Directors...

XOMA : 26.62 (-1.88%)
XOMA Royalty Declares Quarterly Preferred Stock Dividends GlobeNewswire - Thu Dec 19, 6:30AM CST

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Acquires Pulmokine, Adding Seralutinib as its Seventh Phase 3 Royalty Asset Quiver Quantitative, Inc. - Mon Dec 2, 4:48PM CST

XOMA Royalty acquires seralutinib, enhancing its Phase 3 royalty assets targeting pulmonary arterial hypertension.Quiver AI SummaryXOMA Royalty Corporation has acquired an economic interest in seralutinib,...

XOMA : 26.62 (-1.88%)
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio GlobeNewswire - Mon Dec 2, 6:30AM CST

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty: Q3 Earnings Snapshot AP - Thu Nov 7, 6:52AM CST

XOMA Royalty: Q3 Earnings Snapshot

XOMA : 26.62 (-1.88%)
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities GlobeNewswire - Thu Nov 7, 6:30AM CST

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience GlobeNewswire - Tue Oct 22, 7:00AM CDT

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty: Q2 Earnings Snapshot AP - Tue Aug 13, 6:39AM CDT

XOMA Royalty: Q2 Earnings Snapshot

XOMA : 26.62 (-1.88%)
Xoma: Q1 Earnings Snapshot AP - Thu May 9, 7:00AM CDT

Xoma: Q1 Earnings Snapshot

XOMA : 26.62 (-1.88%)
DocuSign, Gap rise; Costco, Marvell fall, Friday, 3/8/2024 Associated Press - Fri Mar 8, 3:15PM CST

Stocks that traded heavily or had substantial price changes on Friday: DocuSign, Gap rise; Costco, Marvell fall

XOMA : 26.62 (-1.88%)
GPS : 24.55 (+4.38%)
MDB : 242.92 (-1.10%)
COST : 949.91 (-0.44%)
DOCU : 95.80 (+1.47%)

Barchart Exclusives

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases Barchart - Mon Dec 23, 3:37PM CST
The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot